Changing the Course of Drug Shortages

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology, Regulatory Sourcebook, September 2021, Volume 2021 eBook, Issue 3
Pages: 16-22

The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.

Drug shortages were a major concern before the COVID-19 pandemic, which only served to further add pressure to an imperfect supply chain. The COVID-19 pandemic placed added pressure on bio/pharma’s imperfect supply chain, contributing to ongoing drug shortages and creating some new challenges. What has the industry learned from the pandemic and will practices and supply-related decisions change going forward?

Regulatory Sourcebook

Read this article in Pharmaceutical Technology's September 2021 Regulatory Sourcebook.


About the author

Meg Rivers is a senior editor at Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.

Article Details

Pharmaceutical Technology
eBook: Regulatory Sourcebook, September 2021
September 2021
Pages: 16-22


When referring to this article, please cite it as M. Rivers, “Changing the Course of Drug Shortages," Pharmaceutical Technology Regulatory Sourcebook eBook (September 2021).